More studies are ongoing to understand further the full extent of semaglutide's cardiovascular benefits and potential uses in other cardiovascular-risk populations
It is a mix of behavior and biology, but I would say it leans heavily toward biology. When you lose weight, the body employs a number of defense mechanisms
According to the results, taking a GLP-1 (such as Ozempic) for weight loss was associated with a higher risk of pancreatitis, bowel obstruction, and gastroparesis than bupropion-naltrexone
These effects lead to improved glycaemic control and significant weight loss
For individuals undergoing treatment with Ozempic, it is critical to maintain open communication with healthcare providers about any new or worsening symptoms
In the U.S., compounded semaglutide generally comes from two types of pharmacies recognized by the Food and Drug Administration (FDA): 503A or 503B pharmacies